Shanghai Shen Lian Biomedical Corporation (SHA:688098)
China
· Delayed Price · Currency is CNY 8.88
-0.05 (-0.56%)
Apr 30, 2026, 9:54 AM CST
SHA:688098 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -24.97 | -44.74 | 31.52 | 61.1 | 110.2 | Upgrade
|
| Depreciation & Amortization | 75.43 | 68.36 | 63.45 | 57.07 | 43.74 | Upgrade
|
| Other Amortization | - | 0.28 | - | - | - | Upgrade
|
| Loss (Gain) From Sale of Assets | -0.26 | -0.04 | -0 | -0.14 | 0.6 | Upgrade
|
| Asset Writedown & Restructuring Costs | -2.37 | 28.46 | 0.4 | 0.24 | - | Upgrade
|
| Loss (Gain) From Sale of Investments | 3 | -2.67 | -5.79 | -3.31 | -12.08 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 8.45 | 3.12 | 8.5 | 1.65 | Upgrade
|
| Other Operating Activities | 13.9 | -3.93 | -1.68 | -0.11 | -5.82 | Upgrade
|
| Change in Accounts Receivable | -34.22 | 5.03 | -52.18 | -78.96 | -27.68 | Upgrade
|
| Change in Inventory | 0.64 | 16.68 | 3.58 | -11.9 | -32.27 | Upgrade
|
| Change in Accounts Payable | 3.29 | 21.42 | -33.15 | -17.88 | 5.25 | Upgrade
|
| Change in Other Net Operating Assets | - | - | -6.81 | -6.14 | 5.07 | Upgrade
|
| Operating Cash Flow | 33.08 | 89.36 | 3.53 | 9.09 | 90.12 | Upgrade
|
| Operating Cash Flow Growth | -62.99% | 2434.71% | -61.21% | -89.92% | -19.34% | Upgrade
|
| Capital Expenditures | -45.23 | -84.91 | -129.63 | -93.12 | -188.16 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.52 | - | - | 0.86 | 0.5 | Upgrade
|
| Investment in Securities | -8 | 78.94 | 141.45 | 119.3 | 49.4 | Upgrade
|
| Other Investing Activities | 3.55 | 2.29 | 10.05 | 8.98 | 11.06 | Upgrade
|
| Investing Cash Flow | -49.16 | -3.68 | 21.86 | 36.01 | -127.21 | Upgrade
|
| Long-Term Debt Issued | - | 14 | - | - | - | Upgrade
|
| Total Debt Issued | - | 14 | - | - | - | Upgrade
|
| Long-Term Debt Repaid | -1.12 | -0.78 | -0.37 | -0.12 | -0.14 | Upgrade
|
| Net Debt Issued (Repaid) | -1.12 | 13.22 | -0.37 | -0.12 | -0.14 | Upgrade
|
| Issuance of Common Stock | - | - | - | - | 8.14 | Upgrade
|
| Common Dividends Paid | -0.27 | -14.35 | -32.77 | -36.81 | -40.81 | Upgrade
|
| Other Financing Activities | -2.12 | -18.23 | 0.05 | 0.24 | 0.51 | Upgrade
|
| Financing Cash Flow | -3.51 | -19.36 | -33.09 | -36.7 | -32.3 | Upgrade
|
| Foreign Exchange Rate Adjustments | -0 | 0 | 0 | 0 | -0 | Upgrade
|
| Net Cash Flow | -19.59 | 66.33 | -7.71 | 8.4 | -69.39 | Upgrade
|
| Free Cash Flow | -12.16 | 4.45 | -126.11 | -84.04 | -98.04 | Upgrade
|
| Free Cash Flow Margin | -4.22% | 1.47% | -41.83% | -25.57% | -27.35% | Upgrade
|
| Free Cash Flow Per Share | -0.03 | 0.01 | -0.32 | -0.21 | -0.24 | Upgrade
|
| Cash Income Tax Paid | 12.23 | 15.06 | 30.93 | 24.25 | 28.43 | Upgrade
|
| Levered Free Cash Flow | 19.38 | 18.35 | -113.08 | -92.62 | -126.34 | Upgrade
|
| Unlevered Free Cash Flow | 19.38 | 18.36 | -113.08 | -92.62 | -126.34 | Upgrade
|
| Change in Working Capital | -31.66 | 35.19 | -87.5 | -114.26 | -48.17 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.